Zydus Cadila Launches Ujvira, First Antibody Drug Conjugate (ADC) Breast Cancer Treatment
Zydus Cadila has launched Trastuzumab Emtansine, the first antibody Drug Conjugate (ADC) biosimilar for early and advanced HER2 positive Breast Cancer Patients’ treatment. The drug has been launched under the…
Share